To support the high-quality development of technological innovation projects in the medical device field, promote deep collaboration and cooperation among technology resources, high-quality enterprises, investment institutions, and industrial clusters, the 2024GEW (18th) Global Entrepreneurship Week China Station, the Yangtze River Delta Innovation and Entrepreneurship Development Alliance, Shanghai Enterprise Service Cloud, and Guoqian Venture Capital jointly held the DoerLink Relay Annual Roadshow - Medical Device Special Session. This roadshow will invite 8 technology innovation enterprises and projects, 40+professional investors, and efficiently carry out investment and financing docking, as well as university achievement transformation and exchange roadshows.
We gather together on the GEW (Global Entrepreneurship Week China) platform, with innovation at the forefront and financing as the wings, to empower innovation and entrepreneurship projects and witness their growth and transformation together!
Xinqing Medical (Suzhou) Co., Ltd. (hereinafter referred to as "Xinqing Medical") was founded in May 2017 by Dr. Xu Boling, a young expert of the National Major Talent Project, the first Chinese member of the International Society for Mechanical Circulation Assistance (ISMCS), and a specially appointed professor at Soochow University. Together with a team of top experts at home and abroad who have long been engaged in the development of artificial organs, Xinqing Medical is committed to creating a multi organ life support platform starting from heart failure
Dongfang Bay (Yangzhou) Biological New Materials Co., Ltd. was established in 2019 and is a leading ecological material research and manufacturing enterprise in China. The world's first commercial digital manufacturing lighthouse factory for 20000 ton PLA bio composite fibers, achieving large-scale production of 20000 ton polylactic acid two-component fibers (SUSIE®). Zhu Meifang, academician of the Chinese Academy of Sciences, is the chief scientist of the enterprise. Supported by Ningbo Institute of the Chinese Academy of Sciences, Donghua University, and Jicui Advanced Fiber Research Institute, the product has the characteristics of excellent performance, health and safety, natural skin affinity, ecological bacteriostasis, and environmental friendliness. At present, it has signed strategic cooperation agreements with many top 500 enterprises, such as non-woven fabrics, yarns, personal care products, and clothing, to enable the technology of the whole industry chain.
Suzhou Nawei Zhikang Technology Co., Ltd. provides a set of intelligent full process solutions for the field of bone and joint. This plan covers a complete closed-loop process from preoperative preparation, intraoperative operation, postoperative recovery, and follow-up based on different scenario requirements. By building the EPJOENT cloud platform system, with surgical robots as the core, including planning software, electronic surgical navigation, and other efficient product lines, we aim to promote close innovative collaboration among "industry, academia, research, and medicine". Simultaneously possessing comprehensive capabilities such as platform supply and demand information docking, big data technology application, remote medical security control, and standardized services.
PUHENG BIOMEDICANE (Shanghai) Co., Ltd. is an innovative enterprise dedicated to the research and application of new in vitro 3D culture technology. The NAC-0rgan technology independently developed by the enterprise is the world's first assembled in vitro 3D culture technology based on nano nucleic acid materials, which can quickly achieve high-throughput and standardized production of humanized complex organ/disease models. The company has utilized the advantages of NAC Organ technology to create an in vitro 3D organ modeling system featuring chronic disease models, immune microenvironment models, etc. It has established a library of common chronic diseases, multiple tumors, important physiological organs, and multi organ composite models, and built a high-throughput drug efficacy and safety testing and analysis platform. It has provided efficient and accurate research and development services to many well-known domestic and foreign enterprises, clinical hospitals, and research institutes, and has been highly recognized by customers. At the same time, the company has successfully utilized the advantages of NAC Organ technology to develop 3D micro tissue therapy technology with more efficient implantation and repair capabilities, actively laying out the clinical application of next-generation regenerative therapy technology.
Suzhou Bangqi Biotechnology Co., Ltd.'s product coverage is self exempt; The instruments and reagents for allergy diagnosis are developed by Bangqi Biotechnology through self-developed instruments and diagnostic reagents; In the field of in vitro allergy diagnosis, two major detection platforms, namely fully automated, short reporting period, high-throughput, and high-sensitivity immunoblotting and flow cytometry fluorescence, have been launched. The products have obtained 8 registration certificates in Jiangsu, and nearly 50 products are in the process of registration application, which will provide higher quality, faster, and more accurate clinical diagnostic basis for clinical practice. Bangqi Biotechnology has been honored as a high-tech enterprise, selected as a leading talent in entrepreneurship in Gusu, and a unicorn enterprise in Xiangcheng District.
YESight (Suzhou) Medical Technology Co., Ltd. is an enterprise that focuses on innovation in ophthalmic medical devices, integrating the research and development, production, sales, and AI big data research of innovative ophthalmic optical platforms. Our self-developed equipment currently focuses on ultra wide angle confocal laser scanning ophthalmoscope (SLO). The company has a senior technical team consisting of Fortune Global 500 companies, internationally renowned ophthalmic equipment companies, and nearly 20 years of work experience, with profound accumulation in core image processing, optical design, industrialization, and engineering fields; Establish production and research centers in Suzhou and overseas respectively, based on high-end ophthalmic optical platforms, to innovate ophthalmic diagnosis and screening technologies. YESight Medical is committed to shaping the top domestic ultra wide angle SLO brand. We adhere to the research and development philosophy of "smarter, more comfortable, and more portable", integrating modern technology into every detail, aiming to bring brightness and hope to every pair of eyes and become the "shining light that illuminates the field of vision".
Di Ma Biotechnology Co., Ltd. is a biotechnology company dedicated to preclinical research and development of potential drug targets. Di Ma Biotechnology has currently completed the preparation of over 460 drug targets and more than 5000 lead antibody molecules in stock. Our zero cycle, zero risk, and zero down payment spot product business model has completely overturned the current conventional CRO customization service model. We provide pharmaceutical clients with more economical and rapid drug target antibody discovery solutions. At the same time, the collection of full-length multi transmembrane protein nanodisk products by Code Bio is currently the most comprehensive in the world.
Suzhou Yingsai Feiying Medical Technology Co., Ltd. is a leading provider of comprehensive smart healthcare solutions, focusing on the research and development, production, and sales of wireless high-end medical equipment for minimally invasive surgery. The company received angel round fund investment in the year of its establishment, with its headquarters located in Suzhou High tech Zone and its R&D and marketing center located in Minhang District, Shanghai. The company has gathered a team of experts with many years of industry experience. The founder, Dr. Meng Fan (Shanghai Jiao Tong University), has been dedicated to research in the field of medical imaging, with a focus on the development of endoscopic equipment and medical robots. The R&D team is mainly composed of doctoral and master's students from Shanghai Jiao Tong University. The core team has undertaken the key project of digital diagnosis and treatment equipment research and development under the 2019 National Key R&D Program of the Ministry of Science and Technology and participated in the completion of several major national projects, mainly involving the research and development of various endoscopes and underlying technology research. The company has successfully developed the world's first ultra high definition wireless endoscope system, which features miniaturization, portability, and intelligence.
Guoqian is honored to join hands with ecological partners, excellent project teams, and investor partners to exchange ideas and achieve win-win cooperation at GEW, the most influential event in the global entrepreneurship field. Guoqian will continue to provide efficient financing connections for entrepreneurs and assist in the growth of entrepreneurial projects.
About Guoqian
Guoqian Medical Technology (Suzhou) Co., Ltd. is jointly invested and established by Dr. Zhang Xu and seven other national major talent engineering experts who have successfully innovated and started businesses in the fields of biomedical and medical devices, as well as shareholders in other fields.
Guoqian Medical is committed to investing in medical device innovation technology industry, entrepreneurial incubation, and precise empowerment. Guoqian Venture Capital Management (Suzhou) Co., Ltd., a wholly-owned subsidiary, is a venture capital firm specializing in early-stage equity investment in medical devices. Adhering to the business philosophy of "achieving others' dreams", Guoqian Venture Capital invests and aggregates industries through its managed equity investment funds, while Guoqian Medical creates an industrial ecosystem through incubation and empowerment. The two business platforms are highly coordinated, creating a high-end medical equipment industry cluster and ecosystem in Suzhou High tech Zone.